Clinical Pharmacology in Drug Development
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.7 | Q3 | 25.3% | 0.553 | Q2 | 64.8% |
| 2024 | 1.8 | Q3 | 31.2% | 0.691 | Q2 | 73.1% |
| 2023 | 1.5 | Q3 | 26.4% | 0.626 | Q2 | 72.3% |
| 2022 | 2.0 | Q4 | 33.0% | 0.637 | Q2 | 73.9% |
| 2021 | 2.2 | Q4 | 39.4% | 0.531 | Q2 | 69.1% |
| 2020 | — | — | 0.711 | Q2 | 76.6% | |
| 2019 | — | — | 0.494 | Q2 | 67.2% | |
| 2018 | — | — | 0.573 | Q2 | 69.4% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2160-763X
ISSN
2160-7648
country
UScoverage
2012-2026